Skip to main content

Washington Life Sciences Group Provides Support for MDx, CTC Projects

NEW YORK (GenomeWeb News) – The Life Sciences Discovery Fund, a Washington State agency that supports innovative research and development projects, has awarded $1 million to fund several new research projects, including efforts to develop new molecular and other diagnostic technologies.

One of the new awards will provide $250,000 to University of Washington Professor Gerard Cangelosi to develop and evaluate a rapid test for detecting common hospital-acquired infections, LSDF said on Friday.

Cangelosi will lead a project to develop high-sensitivity, high-specificity molecular viability testing technology with commercialization partner AttoDx, a Seattle-based firm that has an exclusive license to intellectual property on which the test is based. AttoDx also plans to create an instrument to automate the test through a parallel research project.

UW Professor Daniel Chiu won an $80,000 LSDF award to validate technologies he developed under earlier funding to detect recurrences of cancer early on. The technology Chiu has developed isolates circulating tumor cells (CTCs), and he will use this grant to validate and increase the specificity of the CTC assay.

These efforts should help to bring this assay closer to commercialization through two spinout companies that Chiu has already launched.

LSDF also said it is currently accepting early applications from Washington-based for-profit and non-profit organizations for up to $6.5 million in funding through two grant programs.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.